Provider
Interleukin-13 (IL-13) Antagonist - Medicaid
Program effective Date: Apr 01, 2025
Documents & Forms Results
Displaying 51 - 60 of 3102 results
Provider
Interleukin-13 (IL-13) Antagonist - Commercial
Program effective Date: Apr 01, 2025
Provider
Opioid Immediate Release (IR) and Extended Release (ER) New To Therapy with Daily QL - Medicaid
Program effective Date: Apr 01, 2025
Provider
Pseudobulbar Affect (PBA) - Medicaid
Program effective Date: Apr 01, 2025
Provider
Pseudobulbar Affect (PBA) - Commercial
Program effective Date: Apr 01, 2025
Provider
Interleukin-5 (IL-5) Inhibitors - Medicaid
Program effective Date: Apr 01, 2025
Provider
Interleukin-5 (IL-5) Inhibitors - Commercial
Program effective Date: Apr 01, 2025
Provider
Interleukin-4 (IL-4) Inhibitors - Medicaid
Program effective Date: Apr 01, 2025
Provider
Interleukin-4 (IL-4) Inhibitors - Commercial
Program effective Date: Apr 01, 2025
Provider
Oxybate - Commercial
Program effective Date: Apr 01, 2025